New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD-Reference-Cited by-同舟云学术

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD

Published:2019-08 Issue:2 Volume:71 Page:389-396
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Boursier Jérôme^ORCID,Guillaume Maeva^ORCID,Leroy Vincent,Irlès Marie,Roux Marine,Lannes Adrien,Foucher Juliette,Zuberbuhler Floraine,Delabaudière Cyrielle,Barthelon Justine,Michalak Sophie,Hiriart Jean-Baptiste,Peron Jean-Marie,Gerster Theophile,Le Bail Brigitte,Riou Jeremie^ORCID,Hunault Gilles,Merrouche Wassil,Oberti Frederic,Pelade Laurence,Fouchard Isabelle,Bureau Christophe,Calès Paul,de Ledinghen Victor

Funder

University Hospital of Angers

Publisher

Elsevier BV

Subject

Hepatology

Reference31 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis;Dulai;Hepatology,2017

3. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease;J Hepatol,2016

4. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis;J Hepatol,2015

5. Nonalcoholic steatohepatitis;Diehl;N Engl J Med,2018

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial;BMC Pediatrics;2024-08-20

2. Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction‐associated steatotic liver disease;Alimentary Pharmacology & Therapeutics;2024-08-14

3. One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population;United European Gastroenterology Journal;2024-08-04

4. Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity;Alimentary Pharmacology & Therapeutics;2024-05-30

5. Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease;Hepatobiliary Surgery and Nutrition;2024-04